Yin DL - Search Results

1

Overcoming tumor drug resistance with high-affinity taxanes: a SAR study of C2-modified 7-acyl-10-deacetyl cephalomannines.

Yang CG, Barasoain I, Li X, Matesanz R, Liu R, Sharom FJ, Yin DL, Díaz JF, Fang WS. Yang CG, et al. Among authors: yin dl. ChemMedChem. 2007 May;2(5):691-701. doi: 10.1002/cmdc.200700002. ChemMedChem. 2007. PMID: 17385753

2

Synthesis and biological evaluation of taxinine analogues as orally active multidrug resistance reversal agents in cancer.

Zhao X, Gu J, Yin D, Chen X. Zhao X, et al. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4767-70. doi: 10.1016/j.bmcl.2004.06.089. Bioorg Med Chem Lett. 2004. PMID: 15324905

3

Synthesis and structure-activity relationships of sinenxan A derivatives as multidrug resistance reversal agents.

Huang M, Zhao X, Zhang M, Gu J, Chen X, Yin D. Huang M, et al. Bioorg Med Chem Lett. 2010 Sep 15;20(18):5418-21. doi: 10.1016/j.bmcl.2010.07.099. Epub 2010 Jul 29. Bioorg Med Chem Lett. 2010. PMID: 20709551

4

Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis.

Liu B, Liu K, Lu Y, Zhang D, Yang T, Li X, Ma C, Zheng M, Wang B, Zhang G, Wang F, Ma Z, Li C, Huang H, Yin D. Liu B, et al. Molecules. 2012 Apr 17;17(4):4545-59. doi: 10.3390/molecules17044545. Molecules. 2012. PMID: 22510605 Free PMC article.

5

Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.

He C, Preiss L, Wang B, Fu L, Wen H, Zhang X, Cui H, Meier T, Yin D. He C, et al. ChemMedChem. 2017 Jan 20;12(2):106-119. doi: 10.1002/cmdc.201600441. Epub 2016 Oct 28. ChemMedChem. 2017. PMID: 27792278 Free PMC article.

6

The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structure.

Zhao J, Wang M, Chen J, Luo A, Wang X, Wu M, Yin D, Liu Z. Zhao J, et al. Cancer Lett. 2002 Sep 8;183(1):69-77. doi: 10.1016/s0304-3835(02)00084-8. Cancer Lett. 2002. PMID: 12049816

7

[Synthesis and drug resistant reversal activities of taxane-like multi-drug resistant reversal agents].

Zhang M, Yin DL, Liu HY, Guo JY, Liang XT. Zhang M, et al. Among authors: yin dl. Yao Xue Xue Bao. 2003 Jun;38(6):424-9. Yao Xue Xue Bao. 2003. PMID: 14513801 Chinese.

8

Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action.

Zhang Y, Li H, Wang H, Su F, Qu R, Yin D, Dai J, Li Y, Chen X. Zhang Y, et al. Cancer Chemother Pharmacol. 2010 Oct;66(5):851-9. doi: 10.1007/s00280-009-1229-9. Epub 2010 Jan 6. Cancer Chemother Pharmacol. 2010. PMID: 20052473

9

Four new minor taxanes from cell cultures of Taxus chinensis.

Xie D, Jia HT, Zhang Y, Zou JH, Yin DL, Chen XG, Yan YN, Dai JG. Xie D, et al. Among authors: yin dl. J Asian Nat Prod Res. 2009 Jun;11(6):490-7. doi: 10.1080/10286020902882143. J Asian Nat Prod Res. 2009. PMID: 20183280

10

[Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].

Han B, Huan Y, Lin ZY, Li P, Shen ZF, Yin DL, Huang HH. Han B, et al. Among authors: yin dl. Yao Xue Xue Bao. 2010 Nov;45(11):1379-84. Yao Xue Xue Bao. 2010. PMID: 21361038 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters